COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 165 filers reported holding COHERUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,262 | +84.5% | 3,815 | +110.8% | 0.00% | – |
| Q2 2023 | $7,728 | -37.6% | 1,810 | 0.0% | 0.00% | – |
| Q1 2023 | $12,380 | -14.5% | 1,810 | 0.0% | 0.00% | – |
| Q4 2022 | $14,482 | +1348.2% | 1,810 | +2054.8% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 84 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -87.5% | 84 | -85.3% | 0.00% | – |
| Q1 2022 | $8,000 | -66.7% | 571 | -62.8% | 0.00% | – |
| Q4 2021 | $24,000 | +41.2% | 1,537 | +37.5% | 0.00% | – |
| Q3 2021 | $17,000 | +70.0% | 1,118 | +50.1% | 0.00% | – |
| Q2 2021 | $10,000 | +66.7% | 745 | +69.7% | 0.00% | – |
| Q1 2021 | $6,000 | +50.0% | 439 | +116.3% | 0.00% | – |
| Q4 2020 | $4,000 | -78.9% | 203 | -80.6% | 0.00% | – |
| Q3 2020 | $19,000 | +90.0% | 1,045 | +91.7% | 0.00% | – |
| Q2 2020 | $10,000 | -87.8% | 545 | -89.4% | 0.00% | – |
| Q1 2020 | $82,000 | – | 5,165 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |